SCHEMBL25501050

SCHEMBL25501050

O=c1c2ccccc2sc2nc3cc4[nH]c5ccc(-c6ccccc6)cc5c4cc3n12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
HPGD P15428 2/20 0.52
HSD17B10 Q99714 2/20 0.52
NPC1 O15118 2/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
GABRA1 P14867 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRA6 Q16445 2/20 0.36
FEN1 P39748 1/20 0.36
PIM1 P11309 1/20 0.35
PIM3 Q86V86 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
CDK4 P11802 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23902950 0.89 KDM4E (0.55) KDM4EHPGDHSD17B10NPC1LMNA
SCHEMBL24513417 0.78 KDM4E (0.71) KDM4EHPGDHSD17B10NPC1LMNA
SCHEMBL24513420 0.78 KDM4E (0.71) KDM4EHPGDHSD17B10NPC1LMNA
SCHEMBL23902934 0.78 NPC1 (0.51) NPC1RAB9AGABRA1GABRG2GABRB3
SCHEMBL26226937 0.78 KDM4E (0.53) KDM4EHPGDHSD17B10NPC1LMNA
SCHEMBL26226942 0.78 SMN1; SMN2 (0.53) KDM4EHPGDHSD17B10NPC1LMNA
SCHEMBL26227186 0.78 KDM4E (0.56) KDM4EHPGDHSD17B10NPC1LMNA
SCHEMBL23903031 0.77 RAB9A (0.53) KDM4EHPGDHSD17B10NPC1LMNA
SCHEMBL23903192 0.77 KDM4E (0.60) KDM4EHPGDHSD17B10NPC1LMNA
SCHEMBL24513170 0.77 KDM4E (0.57) KDM4EHPGDHSD17B10NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION DDT, EPCAM, SLC18A3 KDM4E 3347/4885HPGD 3959/4885HSD17B10 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.